Cargando…
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
PURPOSE: The American College of Surgeons Oncology Group trial Z0011 demonstrated that axillary node dissection (ALND) can be omitted in patients managed with breast conserving surgery and 1 to 2 positive sentinel lymph nodes (SLNs) without adverse effects on locoregional recurrence or disease-free...
Autores principales: | Gebhardt, Brian J., Thomas, Joel, Horne, Zachary D., Champ, Colin E., Farrugia, Daniel J., Diego, Emilia, Ahrendt, Gretchen M., Beriwal, Sushil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127974/ https://www.ncbi.nlm.nih.gov/pubmed/30197938 http://dx.doi.org/10.1016/j.adro.2018.03.004 |
Ejemplares similares
-
Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019) -
Axillary Treatment Management in Breast Cancer during COVID-19 Pandemic (Association between ACOSOG Z0011 Criteria and OSNA Test)
por: Anedda, Giacomo, et al.
Publicado: (2023) -
The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study
por: Liu, Miao, et al.
Publicado: (2015) -
Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study
por: Peng, Yuan, et al.
Publicado: (2021) -
Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
por: Jung, Jiwoong, et al.
Publicado: (2020)